Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$66.18 - $83.18 $3,309 - $4,159
-50 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$63.34 - $74.11 $1,583 - $1,852
25 Added 100.0%
50 $4,000
Q1 2021

May 13, 2021

BUY
$76.02 - $100.5 $1,900 - $2,512
25 New
25 $2,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mc Carthy Asset Management, Inc. Portfolio

Follow Mc Carthy Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.